Skip to main content

Table 1 Demographic and clinical characteristics of commercially insured adults with early-onset dementia overall and by receipt of central nervous system polypharmacy

From: Prevalence and trend of central nervous system–active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study

Characteristic

Overall sample

No. (%)

With CNS polypharmacy

No. (%)

Without CNS polypharmacy

No. (%)

P value

Overall

37,563 (100)

8,960 (100)

28,603 (100)

 

Age, y

   

.019

 Mean (SD)

55.9 (7.0)

56.0 (6.9)

55.9 (7.1)

 

 ≤ 44

3532 (9.4)

777 (8.7)

2755 (9.6)

 

 45–49

3463 (9.2)

839 (9.4)

2624 (9.2)

 

 50–54

5764 (15.3)

1373 (15.3)

4391 (15.4)

 

 55–59

9468 (15.6)

2346 (26.2)

7122 (24.9)

 

 60–64

15336 (40.8)

3625 (40.5)

11,711 (40.9)

 

Sex

   

 < .001

 Male

16,279 (43.3)

3225 (36.0)

13,054 (45.6)

 

 Female

21,284 (56.7)

5735 (64.0)

15,549 (54.4)

 

Locale

   

.078

 Metropolitan

27,138 (72.3)

6408 (71.5)

20,730 (72.5)

 

 Rural

10,425 (27.8)

2552 (28.5)

7873 (27.5)

 

US Region

   

 < .001

 Northeast

7618 (20.3)

1473 (16.4)

6145 (21.5)

 

 Midwest

8025 (21.4)

1965 (21.9)

6060 (21.2)

 

 South

17,316 (46.1)

4496 (50.2)

12,820 (44.8)

 

 West

4604 (12.3)

1026(11.5)

3578 (12.5)

 

Clinical condition

    

 Depression

18,019 (48.0)

7048 (78.7)

10,971 (38.4)

 < .001

 Psychotic disorder

2642 (7.0)

1235 (13.8)

1407 (4.9)

 < .001

 Behavioral symptoms

7361 (19.6)

2679 (29.9)

4682 (16.4)

 < .001

 Chronic pain

16,346 (43.5)

5326 (59.4)

11,020 (38.5)

 < .001

 Epilepsy

4327 (11.5)

1742 (19.4)

2585 (9.0)

 < .001

 Injury

3916 (10.4)

1500 (16.7)

2416 (8.5)

 < .001

 Substance use disorder

4459 (11.9)

1897 (21.2)

2562 (9.0)

 < .001

 CCI (Mean ± SD)

2.2 ± 2.0

2.7 ± 2.1

2.0 ± 1.9

 < .001

Subtype of indexed ADRD diagnosis

   

 < .001

 Dementia with Lewy bodies

495 (1.3)

145 (1.6)

350 (1.2)

 

 Frontotemporal dementia

1160 (3.1)

246 (2.8)

914 (3.2)

 

 Vascular dementia

3132 (8.3)

821 (9.2)

2303 (8.1)

 

 AD/senile dementia

5333 (14.2)

965 (10.7)

4368 (15.3)

 

 Dementia unspecified

27451 (73.1)

6783 (75.7)

20668 (72.3)

 

Year of indexed ADRD diagnosis

   

0.002

 2013

6020 (16.0)

1428 (15.9)

4592 (16.1)

 

 2014

4898 (13.0)

1158 (12.9)

3740 (13.1)

 

 2015

5640 (15.0)

1396 (15.6)

4244 (14.8)

 

 2016

5487 (14.6)

1348 (15.0)

4139 (14.5)

 

 2017

4325 (11.5)

1048 (11.7)

3277 (11.5)

 

 2018

4070 (10.8)

951 (10.6)

3119 (10.9)

 

 2019

3879 (10.3)

821 (9.2)

3058 (10.7)

 

 2020

3244 (8.6)

810 (9.0)

2434 (8.5)

 
  1. Abbreviations: AD Alzheimer’s disease, ADRD Alzheimer’s disease and related dementia, CCI Charlson Comorbidity Index, CNS central nervous system, SD standard deviation